CryoPort, Inc. (NASDAQ:CYRX) Given Consensus Recommendation of “Moderate Buy” by Brokerages

CryoPort, Inc. (NASDAQ:CYRX) has been assigned a consensus rating of “Moderate Buy” from the ten ratings firms that are covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, one has issued a hold rating and eight have given a buy rating to the company. The average twelve-month target price among brokers that have covered the stock in the last year is $12.8333.

CYRX has been the subject of several recent analyst reports. UBS Group upped their price target on CryoPort from $11.00 to $12.50 and gave the stock a “buy” rating in a research note on Wednesday, November 5th. Needham & Company LLC upped their target price on CryoPort from $11.00 to $12.00 and gave the stock a “buy” rating in a research report on Wednesday, November 5th. Finally, Weiss Ratings reiterated a “sell (d+)” rating on shares of CryoPort in a report on Monday, December 29th.

Insider Buying and Selling

In related news, Director Ramkumar Mandalam sold 11,570 shares of CryoPort stock in a transaction on Wednesday, December 10th. The shares were sold at an average price of $9.99, for a total value of $115,584.30. Following the transaction, the director owned 80,758 shares in the company, valued at $806,772.42. This trade represents a 12.53% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 10.00% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of CYRX. Millennium Management LLC lifted its position in CryoPort by 23.8% during the 4th quarter. Millennium Management LLC now owns 3,244,802 shares of the company’s stock worth $31,150,000 after buying an additional 623,896 shares in the last quarter. Vanguard Group Inc. raised its stake in shares of CryoPort by 2.5% in the third quarter. Vanguard Group Inc. now owns 2,858,031 shares of the company’s stock worth $27,094,000 after acquiring an additional 69,550 shares during the last quarter. Thematics Asset Management lifted its position in shares of CryoPort by 12.8% during the second quarter. Thematics Asset Management now owns 1,914,885 shares of the company’s stock worth $14,285,000 after purchasing an additional 216,937 shares in the last quarter. Assenagon Asset Management S.A. grew its stake in shares of CryoPort by 37.4% during the third quarter. Assenagon Asset Management S.A. now owns 1,498,774 shares of the company’s stock valued at $14,208,000 after purchasing an additional 408,263 shares during the last quarter. Finally, UBS Group AG increased its holdings in shares of CryoPort by 6.8% in the fourth quarter. UBS Group AG now owns 1,421,884 shares of the company’s stock valued at $13,650,000 after purchasing an additional 90,363 shares in the last quarter. 92.90% of the stock is owned by institutional investors.

CryoPort Price Performance

NASDAQ CYRX opened at $8.48 on Thursday. The company has a quick ratio of 15.01, a current ratio of 15.77 and a debt-to-equity ratio of 0.40. The stock has a market capitalization of $424.59 million, a PE ratio of 7.25 and a beta of 1.66. CryoPort has a 12-month low of $4.58 and a 12-month high of $11.45. The company has a 50 day moving average price of $9.61 and a two-hundred day moving average price of $9.41.

About CryoPort

CryoPort, Inc (NASDAQ: CYRX) is a global provider of temperature-controlled logistics solutions for the life sciences industry. The company specializes in cryogenic shipping for critical biological materials, supporting the development, clinical testing and commercialization of cell and gene therapies, biologics, vaccines and reproductive medicine. By offering end-to-end supply chain management, CryoPort helps ensure the integrity and viability of temperature-sensitive products from point of origin to destination.

CryoPort’s product portfolio includes proprietary cryogenic dry shippers, advanced active and passive thermal packaging, and real-time data monitoring platforms.